Cancers of the Head and Neck Approved for Marketing Phase Trials for Gefitinib (DB00317)

Also known as: Cancer of the Head and Neck

IndicationStatusPhase
DBCOND0065283 (Cancers of the Head and Neck)Approved for MarketingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00684385An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck